Brind.

Entities / Government agency

Swissmedic.

licensing and inspection authority for remedies in Switzerland with headquarters in Bern

Seen in 6 reportsLast reported Oct 13

Reports this week: 0
Active events: 0
Connections: 11

What's happening

One to three months ago

Novartis sought Swissmedic regulatory approval for a drug, which was co-funded by Sida and introduced first in Ghana.

Some support1 report

Gone quiet

No new reports in 90+ days

Swissmedic approved a new malaria medicine from Novartis on July 8, 2025.

Speculative1 report
Mainz Biomed N.V. received regulatory approval from Swissmedic in Switzerland on August 13, 2025, allowing ColoAlert® to be marketed in select European countries.

Some support2 reports

Around Swissmedic this week

News at the entities that move Swissmedic most

Novartis Structural
Sean Maenpaa, with experience at Novartis and Celgene, was appointed SVP Business Development at Clovis Oncology.

Moves Swissmedic
Fri 12:53
Ghana Mentioned together
The National Development Planning Commission guided national development planning in Ghana and made a call at the University of Ghana.

Moves Swissmedic
14:19

Connections

The 2 strongest of 11, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.

Novartis Structural

Novartis relies on Swissmedic for product approval and market access in Switzerland.

Some supportSep 15

Swissmedic → Novartis
Novartis → Swissmedic
Ghana Mentioned together

The evidence places Ghana as the location where a drug was introduced, while Swissmedic is a related regulatory body mentioned in the same context.

Some supportSep 15

Swissmedic → Ghana
Ghana → Swissmedic

History

Events by the month they began

September 2026

1 event

Sep 15, 2026Novartis sought Swissmedic regulatory approval for a drug, which was co-funded by Sida and introduced first in Ghana.

June 2026

2 events